Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.10.1 (
ERK
)
95,504
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
HTK
is a receptor tyrosine kinase that belongs to the Eph subfamily. An extensive screening using BIAcore system revealed that a colon cancer cell line, C-1, expressed the ligand for
HTK
. From the conditioned medium of C-1 cells, a soluble form of ligand was purified by receptor affinity chromatography, and the isolation of full-length cDNA revealed that this ligand is identical to the human
HTK ligand
(
HTKL
) previously reported.
HTK
receptor tyrosine phosphorylation was induced by membrane-bound or clustered soluble
HTKL
but not by unclustered soluble
HTKL
, indicating that
HTKL
requires cell-to-cell interaction for receptor activation. Binding analysis demonstrated that
HTKL
binds to
HTK
with a much higher affinity (Kd: 1.23 nM) than the other transmembrane-type ligand for Eph family, LERK-2/ELKL (Kd: 135 nM). The expression of
HTK
in cord blood cells was upregulated after the culture in the presence of stem cell factor. Clustered soluble
HTKL
stimulated the proliferation of sorted HTK+ cord blood cells and a hematopoietic cell line, UT-7/EPO from which
HTK
was isolated. These findings suggest the involvement of
HTK
-
HTKL
system in the proliferation of HTK+ hematopoietic progenitor cells in the hematopoietic environment.
...
PMID:Characterization of a ligand for receptor protein-tyrosine kinase HTK expressed in immature hematopoietic cells. 876 3
Receptor tyrosine kinases of the
EPH
class have been implicated in the control of axon guidance and fasciculation, in regulating cell migration, and in defining compartments in the developing embryo. Efficient activation of
EPH
receptors generally requires that their ligands be anchored to the cell surface, either through a transmembrane (TM) region or a glycosyl phosphatidylinositol (GPI) group. These observations have suggested that
EPH
receptors can transduce signals initiated by direct cell-cell interaction. Genetic analysis of
Nuk
, a murine
EPH
receptor that binds TM ligands, has raised the possibility that these ligands might themselves have a signalling function. Consistent with this, the three known TM ligands have a highly conserved cytoplasmic region, with multiple potential sites for tyrosine phosphorylation. Here we show that challenging cells that express the TM ligands Elk-L or
Htk-L
with the clustered ectodomain of
Nuk
induces phosphorylation of the ligands on tyrosine, a process that can be mimicked both in vitro and in vivo by an activated Src tyrosine kinase. Co-culture of cells expressing a TM ligand with cells expressing
Nuk
leads to tyrosine phosphorylation of both the ligand and
Nuk
. These results suggest that the TM ligands are associated with a tyrosine kinase, and are inducibly phosphorylated upon binding
Nuk
, in a fashion reminiscent of cytokine receptors. Furthermore, we show that TM ligands, as well as
Nuk
, are phosphorylated on tyrosine in mouse embryos, indicating that this is a physiological process.
EPH
receptors and their TM ligands therefore mediate bidirectional cell signalling.
...
PMID:Bidirectional signalling through the EPH-family receptor Nuk and its transmembrane ligands. 887 83
Molecular gradients have been postulated to control the topographic mapping of retinal axons in their central targets. Based initially on their expression patterns, and more recently on functional studies, members of the EphA subfamily of receptor tyrosine kinases and their ephrin-A ligands have been implicated in the guidance of retinal axons along the anterior-posterior axis of the chick optic tectum. The report that a receptor of the EphB subfamily, EphB2/
Cek5
/
Nuk
/
Sek3
, is expressed in a high ventral to low dorsal gradient in the developing chick retina and is present on ganglion cell axons suggests that it may be involved in the mapping of retinal axons along the corresponding dorsal-ventral axis of the tectum. To address this issue, we have determined the expression and distribution of ephrin-B1/LERK-2/
Cek5
-L and ephrin-B2/LERK-5/
Htk-L
/ELF-2, ligands for EphB2, in the developing chick retinotectal system using riboprobes, immunocytochemistry, and receptor affinity probes. Both ephrin-B1 and ephrin-B2 transcripts are expressed in a high dorsal to low ventral gradient in the developing retina, complementary to the distribution of EphB2. Ephrin-B1 and ephrin-B2 proteins are predominantly found in the developing plexiform layers, suggesting a role in the development of intraretinal connections. Neither protein is detected on ganglion cell axons. In tectum, ephrin-B1 transcripts are expressed in a high dorsal to low ventral gradient in the neuroepithelium and the protein is present along the processes of radial glia and is concentrated at their endfeet in the stratum opticum, at the time retinal axons are growing through it. This distribution of ephrin-B1 suggests that it influences retinal axon mapping along the dorsal-ventral tectal axis and may also be involved in intratectal development. In contrast, ephrin-B2 transcripts and protein are localized to the deeper retinorecipient laminae in the tectum at the time retinal axons begin to arborize in them, suggesting that this ligand may influence the laminar patterning of retinal axon terminations.
...
PMID:Graded and lamina-specific distributions of ligands of EphB receptor tyrosine kinases in the developing retinotectal system. 935 68